58345
SUPELCOSIL™ LC-18-DB (5 µm) HPLC Columns
L × I.D. 5 cm × 4.6 mm, HPLC Column
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
NB.21
L × i.d.:
5 cm × 4.6 mm
Particle size:
5 μm
Matrix active group:
C18 (octadecyl) phase
Pore size:
120 Å
Matrix:
silica gel, spherical particle platform
产品名称
SUPELCOSIL™ LC-18-DB HPLC 色谱柱, 5 μm particle size, L × I.D. 5 cm × 4.6 mm
agency
suitable for USP L1
Quality Level
feature
endcapped
manufacturer/tradename
SUPELCOSIL™
extent of labeling
11.0% Carbon loading
parameter
0-70 °C temperature, 400 bar pressure (5801 psi)
technique(s)
HPLC: suitable
L × I.D.
5 cm × 4.6 mm
surface area
170 m2/g
surface coverage
surface coverage 3.1 μmol/m2
matrix
silica gel, spherical particle platform
matrix active group
C18 (octadecyl) phase
particle size
5 μm
pore size
120 Å
application(s)
food and beverages
separation technique
reversed phase
Still not finding the right product?
Explore all of our products under SUPELCOSIL™ LC-18-DB HPLC 色谱柱
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
O Majid et al.
Therapeutic drug monitoring, 23(2), 163-168 (2001-04-11)
Recipients of organ transplants remain particularly dependent on prednisolone as part of their maintenance immunosuppression. Despite this, the pharmacokinetics of prednisolone have never been fully characterized in these patients, and consequently dosing remains empirical. Accurate monitoring of prednisolone, its primary
S L Bramer et al.
Journal of pharmaceutical and biomedical analysis, 26(4), 637-650 (2001-08-23)
An LC/MS/MS method for the simultaneous determination of cilostazol, a quinolinone derivative, and three active metabolites, OPC-13015, OPC-13213, and OPC-13217, in human plasma was developed and validated. Cilostazol, its metabolites, and the internal standard, OPC-3930 were extracted from human plasma
E Terjéki et al.
Journal of pharmaceutical and biomedical analysis, 24(5-6), 913-920 (2001-03-15)
RGH-1756 (1-(2-methoxy-phenyl)-4-(4-[4-(6-imidazo[2,1-b]-thiazolyl)-phenoxy]-butyl)-piperazine dimethansulphonate) is a novel atypical antipsychotic candidate of Gedeon Richter Ltd. A new HPLC method has been developed and validated for the quantitative determination of RGH-1756 in dog and rat plasma. The compound and the internal standard are
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 58345 | 04061833397237 |